About Multani Pharmaceuticals Limited
Multani Pharmaceuticals Limited is a Healthcare company. Testing and manufacturing of Ayurvedic, pharmaceutical, and food products in India. It operates in the Healthcare and Consumer sectors. The company has 483 employees. Its Indian entity Multani Pharmaceuticals Limited reported revenue of ₹274 Cr. Multani Pharmaceuticals Limited offers products and services including Testing Services and Ayurvedic Products. Its focus areas include Pharmaceuticals, Testing Services, Drug and AYUSH Analysis and Food and Beverages.
Company details
Multani Pharmaceuticals Limited is recognized as an NABL accredited testing laboratory that was established in 2008 for the analysis of drugs, AYUSH products, and food items. Approvals for testing Ayurvedic, Unani, and Siddha drugs were granted in 2010 by relevant authorities in Uttarakhand. The laboratory is equipped to handle stability studies and various analyses, including for nutraceuticals and water, serving as a key contract research organization. Over 500 Ayurvedic products are offered in modern packaging for over-the-counter sales, supporting academic, research, and regulatory needs in the sector.
- Employees 483
- SectorsHealthcareConsumer
- Email••••••••
- Social Facebook
- Legal Name Multani Pharmaceuticals Limited
- Date of Incorporation 05 Mar, 1986
- Jurisdiction Delhi, India
- Indian entity revenue₹274 Cr
FY 2025 · +2% YoY
- Indian entity net profit₹28.22 Cr
FY 2025 · 10% margin
- Indian entity EBITDA₹44.29 Cr
FY 2025 · 16% margin
- Employee Count483
Associated legal entities of Multani Pharmaceuticals Limited
Multani Pharmaceuticals Limited operates through Multani Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Multani Pharmaceuticals Limited CIN U24230DL1986PLC023539 | Active | 05 Mar 1986 | New Delhi, Delhi | ₹274 Cr | 483 | 5 | View details |
Products & Services of Multani Pharmaceuticals Limited
Multani Pharmaceuticals Limited offers a comprehensive portfolio of products and services, including Testing Services and Ayurvedic Products.
Testing of drugs, AYUSH products, and food items is conducted to meet regulatory standards
Ayurvedic medicines and OTC products are manufactured and distributed for consumer use
Board of directors of Multani Pharmaceuticals Limited (Multani Pharmaceuticals Limited)
Multani Pharmaceuticals Limited is the primary company behind Multani Pharmaceuticals Limited. The board of Multani Pharmaceuticals Limited currently have 5 directors; the longest-serving is Pradeep Multani, appointed in 1986. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pradeep Multani DIN 00109071 | Director | 08 Mar 1986 | 40 yrs 7 mo | Multani Pharmaceuticals Limited |
| Rajesh Sabharwal DIN 00636236 | Director | 27 Feb 2019 | 7 yrs 7 mo | Multani Pharmaceuticals Limited |
| Yogesh Sahni DIN 00811667 | Director | 27 Feb 2019 | 7 yrs 7 mo | Multani Pharmaceuticals Limited |
| Sanjay Kumar DIN 09271907 | Director | 01 Feb 2023 | 3 yrs 8 mo | Multani Pharmaceuticals Limited |
| Vinay Rungta DIN 09846999 | Director | 01 Feb 2023 | 3 yrs 8 mo | Multani Pharmaceuticals Limited |
Financials of Multani Pharmaceuticals Limited
Figures of Multani Pharmaceuticals Limited, the primary company behind Multani Pharmaceuticals Limited, for FY 2025. Revenue was ₹274 Cr (+2% year on year). Net profit was ₹28.22 Cr (10% margin). EBITDA was ₹44.29 Cr (16% margin). Revenue has grown at a compounded annual rate of +10% over three years and +13% over five years.
- ₹274 CrRevenue · FY 2025 · +2% YoY
- ₹28.22 CrNet profit · 10% margin
- ₹44.29 CrEBITDA · 16% margin
- ₹2.16 CrPaid-up capital
- 483Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Multani Pharmaceuticals Limited are on its company page.
Detailed financial statements for Multani Pharmaceuticals Limited
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Multani Pharmaceuticals Limited
Multani Pharmaceuticals Limited has 483 employees.
The primary company behind Multani Pharmaceuticals Limited, Multani Pharmaceuticals Limited, reported revenue of ₹274 Cr for FY 2025, up 2% year on year.
Multani Pharmaceuticals Limited is recognized as an NABL accredited testing laboratory that was established in 2008 for the analysis of drugs, AYUSH products, and food items. Approvals for testing Ayurvedic, Unani, and Siddha drugs were granted in 2010 by relevant authorities in Uttarakhand. The laboratory is equipped to handle stability studies and various analyses, including for nutraceuticals and water, serving as a key contract research organization. Over 500 Ayurvedic products are offered in modern packaging for over-the-counter sales, supporting academic, research, and regulatory needs in the sector.
Multani Pharmaceuticals Limited offers Testing Services and Ayurvedic Products.
Multani Pharmaceuticals Limited operates through Multani Pharmaceuticals Limited.
The legal entities of Multani Pharmaceuticals Limited currently have 5 directors, including Rajesh Sabharwal, Sanjay Kumar, Pradeep Multani and others.